Combination Anticancer Therapies Using Selected Phytochemicals
Wamidh H Talib1, Dima Awajan1, Reem Ali Hamed1
1Department of Clinical Pharmacy and Therapeutic, Applied Science Private University, Amman 11931-166, Jordan.
Plant-derived natural products offer promising, less toxic alternatives for cancer treatment. This review analyzes phytochemical anticancer mechanisms and combination therapies, aiding research into novel cancer medicines.
Area of Science:
- Oncology
- Pharmacology
- Natural Product Chemistry
Background:
- Cancer remains a leading global health challenge, significantly impacting life expectancy.
- Conventional chemotherapy often exhibits toxicity and lacks selectivity, necessitating alternative treatments.
- Plant-derived natural products show significant potential in cancer therapy due to diverse mechanisms, structures, availability, and lower toxicity.
Purpose of the Study:
- To analyze the anticancer mechanisms of prevalent phytochemicals.
- To discuss the efficacy of combining natural products with each other or with chemotherapeutic drugs.
- To provide a foundation for advancing research in alternative anticancer drug development.
Main Methods:
- Comprehensive literature review of existing research on phytochemicals and cancer.
- Analysis of documented anticancer mechanisms of common plant-derived compounds.
- Evaluation of studies reporting on combination therapies involving natural products and conventional drugs.
Main Results:
- Phytochemicals exhibit multiple anticancer mechanisms, including antiproliferative, apoptotic, anti-angiogenic, and antioxidant effects.
- Combinations of natural products or natural products with chemotherapeutics can enhance efficacy and potentially reduce side effects.
- Synergistic effects observed in combined therapies warrant further investigation.
Conclusions:
- Plant-derived natural products represent a valuable resource for developing novel, safer anticancer agents.
- Combination strategies hold promise for overcoming drug resistance and improving treatment outcomes.
- Further research is crucial for translating these findings into clinical applications for cancer patients.
More Related Videos
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
